THERAFLEX Glucosamine Plus Max

Bayer HealthCare LLC.🇺🇸 United States

FDA Page

Effective Date: Jan 12, 2026
Approval ID: 19d09bb6-f1e9-0477-e054-00144ff8d46c
Products: 1 registered
Version: 11

Regulatory Information

Labeling Type

HUMAN OTC DRUG LABEL

Status

Approved

Full Title

THERAFLEX Glucosamine Plus Max Hard Gelatine Capsules

Quick Stats

Total Products1

Labelers1

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.